InflaRx (IFRX) Current Deferred Revenue (2016 - 2018)

InflaRx has disclosed Current Deferred Revenue across 3 years of filings, most recently posting $13957.6 for Q3 2018.

• Current Deferred Revenue for Q3 2018 came in at $13957.6, down 25.76% year-over-year; the trailing twelve-month figure through Sep 2018 was $13957.6 (down 25.76% YoY), and the FY2017 annual result was $17661.5, down 16.03% from the prior year.
• Current Deferred Revenue came in at $13957.6 for Q3 2018 at InflaRx, down from $15514.8 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $20514.8 in Q4 2016 to a low of $13957.6 in Q3 2018.
• The 3-year median for Current Deferred Revenue is $17430.5 (2018), against an average of $17274.8.
• Across the five-year window, Current Deferred Revenue decreased 13.91% in 2017 and slipped 25.76% in 2018, its largest moves.
• InflaRx's Current Deferred Revenue stood at $20514.8 in 2016, then decreased by 13.91% to $17661.5 in 2017, then dropped by 20.97% to $13957.6 in 2018.
• The last three Current Deferred Revenue figures came in at $13957.6 (Q3 2018), $15514.8 (Q2 2018), and $17199.5 (Q1 2018), per Business Quant data.